1-6 of 6
David Michonneau, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potential of Plasmatic Biomarkers to Predict Acute Gvhd Severity: A Validation Study in a Prospective Cohort of 177 Patients

Marie Robin, MD PhD, Raphael Porcher, PhD, Laetitia Taurines, Bastien Oriano, Regis Peffault De Latour, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Nathalie Dhedin, MD, Christine Chomienne, MD PhD, Gérard Socié, MDPhD, Marie-Hélène Schlageter, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4480.
https://doi.org/10.1182/blood.V130.Suppl_1.4480.4480
Published: 2017
Journal Articles

Outcomes of Hematopoietic Stem Cell Transplantation after Chronic Graft Versus Host Disease and Evaluation of Revised Failure Free Survival in a Retrospective Analysis from Two Referral Centers.

Simona Pagliuca, Flore Sicre De Fontbrune, MD, Antonio M Risitano, MD PhD, David Michonneau, MD PhD, Alban Villate, MD, Rudy Birsen, Camille Rouzaud, Aurelien Sutra del Galy, Nabergoj Mitja, MD, Regis Peffault De Latour, MD PhD, Gérard Socié, MDPhD, Marie Robin, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4578.
https://doi.org/10.1182/blood.V130.Suppl_1.4578.4578
Published: 2017
Journal Articles

Evaluation of Novel Endpoints As Treatment Outcome in Allogeneic Hematopoietic Stem Cell Transplantation: A Comparison of "Classical" and "Refined" Definition of Graft-Versus Host Disease Free and Relapse Free Survival for Registry-Based Studies

Simona Pagliuca, Antonio M Risitano, MD PhD, Flore Sicre De Fontbrune, MD, David Michonneau, MD PhD, Alban Villate, MD, Rudy Birsen, Camille Rouzaud, Aurelien Sutra del Galy, Nabergoj Mitja, MD, Regis Peffault De Latour, MD PhD, Marie Robin, MD PhD, Gérard Socié, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3311.
https://doi.org/10.1182/blood.V130.Suppl_1.3311.3311
Published: 2017
Journal Articles

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Alienor Xhaard, MD, Renato Cunha, MD PhD, Marc Busson, Marie Robin, MD PhD, Nathalie Dhedin, MD, Tereza Coman, MD PhD, Aurelie Cabannes-Hamy, MD, Flore Sicre de Fontbrune, MD, David Michonneau, MD PhD, Gerard Socie, MD PhD, Rodrigo T. Calado, MD PhD, Regis Peffault De Latour, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3478.
https://doi.org/10.1182/blood.V128.22.3478.3478
Published: 2016
Journal Articles

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Simona Pagliuca, MD, Antonio M Risitano, MD PhD, Sylvie Chevret, Flore Sicre de Fontbrune, MD, Alienor Xhaard, MD, Tereza Coman, MD PhD, David Michonneau, MD PhD, Serena Marotta, MD, Mathilde Ruggiu, Swann Bredin, Regis Peffault de Latour, MD PhD, Gérard Socié, MD PhD, Marie Robin, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2285.
https://doi.org/10.1182/blood.V128.22.2285.2285
Published: 2016
Journal Articles

Romiplostim in Patients Undergoing Allogeneic Stem Cell Transplantation: Results of a Phase I/II Multicenter Trial

Régis Peffault de Latour, MD, Sylvie Chevret, MD PhD, Annalisa Ruggeri, MD, Felipe Suarez, MD PhD, Laetitia Souchet, MD, David Michonneau, MD PhD, Flore Sicre de Fontbrune, Tereza Coman, MD PhD, Marie t Rubio, MDPhD, Stéphanie Nguyen, MD PhD, Mohamad Mohty, MD PhD, Gerard Socie, MD PhD
Journal: Blood
Blood (2016) 128 (22): 65.
https://doi.org/10.1182/blood.V128.22.65.65
Published: 2016